The release expands format agnostic capabilities and provides dedicated tools to help scientists make faster decisions with assembled multi-technique analytical data, and delivers new functionality for NMR spectroscopists and mass spectrometrists. Toronto, CANADA —ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced the release of version 2022 software applications […]
The new lab will develop next generation biological threat detection technology and also provides technical support in the manufacture of biosensor disks that enable the BioFlash to detect airborne threats like SARS-CoV-2 and anthrax Smiths Detection, a global leader in the development of threat detection and security screening equipment, opened a biolab at its centre […]
On November 15, Shimadzu Corporation used the prerogative from a stock merger to make Nissui Pharmaceutical Co., Ltd. (hereinafter “Nissui Pharmaceutical,” with Head Office at Taito-ku, Tokyo, and President Tokuya Ono) as a wholly-owned subsidiary. In addition, the corresponding trade name changes and Director/Board Member changes were finalized on November 17 at the Nissui Pharmaceutical […]
Shimadzu Scientific Instruments, a Shimadzu Group company in the United States, and PACE Analytical Services have developed an alternate test procedure (ATP) to EPA method 1613B – PAM-16130-SSI: Determination of 2,3,7,8-Substituted Tetra- through Octa-Chlorinated Dibenzo-p-Dioxins and Dibenzofurans (CDDs/CDFs) Using Shimadzu Gas Chromatography Mass Spectrometry (GC-MS/MS). This ATP allows the use of GC-MS/MS in place of […]
Company sponsors event’s Science Symposium WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at MJBizCon® in Las Vegas next week spotlighting its streamlined and standardized cannabis and hemp testing workflows, solutions, and industry-first New York State pesticide and mycotoxin method – all aimed at helping contract labs and product producers more […]
Driven by Biopharma 4.0, proteomics research and acquisition of TRACE Analytics, 908 Devices empowers more effective drug discoveries BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, continues to equip its life science customers with actionable intelligence at the point-of-need, enabling them to drive advancements in biotherapeutic development. […]
Developed in coordination with the U.S. Forest Service, the MX908 can identify toxic pesticides that pose threats to wildlife, water sources and communities BOSTON — 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the availability of a downloadable target pack for the MX908® to […]
Shimadzu and UMG (University Medical Center Göttingen) team up to develop new clinical LC-MS methods for more rapid and flexible TDM analysis Shimadzu, a global thought leader in innovative laboratory instrumentation, is embarking on a new collaboration with the University Medical Center Göttingen (UMG). UMG is one of Germany’s leading university medical facilities. The collaboration will […]
REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demonstrating the value of at-line cell culture media analysis to inform feeding […]
REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demonstrating the value of at-line cell culture media analysis to inform feeding […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
